Sep 16, 2022 8:42am EDT Benitec Biopharma Inc. Announces Closing of $18 Million Underwritten Public Offering
Sep 12, 2022 10:06pm EDT Benitec Biopharma Inc. Announces Pricing of $18 Million Underwritten Public Offering
Sep 02, 2022 8:00am EDT Benitec Biopharma Releases Full Year 2022 Financial Results and Provides Operational Update
Sep 20, 2021 8:00am EDT Benitec Biopharma Provides Operational Update and Releases its 2021 Fiscal Year-End Financial Results
Sep 13, 2021 3:58pm EDT Benitec Biopharma to present at H.C. Wainwright's 23rd Annual Global Investment Conference
Sep 08, 2021 8:10am EDT Benitec Biopharma Provides Overview of the BB-301 Phase 1b/2a Clinical Trial Design for 2022
Sep 08, 2021 8:05am EDT Benitec Biopharma Provides Positive Updates on the BB-301 Pilot Dosing Study in Large Animals
